Biogen (NASDAQ:BIIB) had its Hold rating reiterated by Barclays with a $250.00 price target – Market Exclusive

Biogen (NASDAQ:BIIB) had its Hold rating reiterated by Barclays with a $250.00 price target – Market Exclusive

Biogen (NASDAQ:BIIB) had its Hold rating reiterated by Barclays with a $250.00 price target – Market Exclusive
Published on 2019-03-22